diabetes

CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
CRISPR, ViaCyte Team Up to Develop Stem Cell-Based Diabetes Therapy
Xconomy
ViaCyte
stem cells
diabetes
CRISPR Therapeutics
Flag link:
Livongo and Abbott Take Diabetes Management to New Heights
Livongo and Abbott Take Diabetes Management to New Heights
Medical Devices and Diagnostics Industry
digital health
Livongo
Abbott Labs
FreeStyle Libre
diabetes
devices
Flag link:
Mellitus Health, Smart Meter ink connected insulin titration deal
Mellitus Health, Smart Meter ink connected insulin titration deal
Drug Delivery Business News
diabetes
devices
Mellitus Health
Smart Meter
insulin titration
Flag link:
Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong
Adocia and Lilly’s legal tussle intensifies as diabetes deal goes wrong
Pharmaforum
Eli Lilly
Adocia
insulin
diabetes
Flag link:
AstraZeneca improves diabetes pen to maintain its market share
AstraZeneca improves diabetes pen to maintain its market share
Pharmaforum
Europe
AstraZeneca
Bydureon BCise
diabetes
injection pen
Flag link:
Boehringer, Lilly diabetes drug Tradjenta succeeds in cardiovascular outcome trial
Boehringer, Lilly diabetes drug Tradjenta succeeds in cardiovascular outcome trial
Pharmaceutical Business Review
Boehringer Ingelheim
Eli Lilly
clinical trials
diabetes
Tradjenta
Flag link:
New Therapy Could Reverse Type 1 Diabetes In Humans And Dogs
New Therapy Could Reverse Type 1 Diabetes In Humans And Dogs
Forbes
type 1 diabetes
animal health
diabetes
collagen
Flag link:
AI And Radar: The Future Of Noninvasive Blood Sugar Monitoring?
AI And Radar: The Future Of Noninvasive Blood Sugar Monitoring?
Forbes
diabetes
blood glucose monitoring
devices
artificial intelligence
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:
Allegro Appoints New CEO and Prepares for Ph III Trials for Diabetic Macular Edema Drug
Allegro Appoints New CEO and Prepares for Ph III Trials for Diabetic Macular Edema Drug
CP Wire
Allegro
Luminate
diabetic macular edema
clinical trials
diabetes
Flag link:
Tandem launches insulin pump with predictive low glucose suspend feature in US
Tandem launches insulin pump with predictive low glucose suspend feature in US
Drug Delivery Business News
devices
Tandem Diabetes
t:slim X2
diabetes
insulin pumps
Flag link:
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
OHSU to Conduct Clinical Trials with Artificial Pancreas Using Xeris' Liquid Glucagon
CP Wire
XERIS
diabetes
artificial pancreas
devices
clinical trials
Flag link:
Medtronic launches engagement program for diabetes patients
Medtronic launches engagement program for diabetes patients
Drug Delivery Business News
Medtronic
devices
diabetes
patients
gamification
Flag link:
The $250 Biohack That’s Revolutionizing Life With Diabetes
The $250 Biohack That’s Revolutionizing Life With Diabetes
Bloomberg
devices
patients
diabetes
artificial pancreas
Medtronic
Flag link:
Abbott Wins Nod for 14 Day Version of Freestyle Libre
Abbott Wins Nod for 14 Day Version of Freestyle Libre
Medical Devices and Diagnostics Industry
devices
Abbott Labs
Freestyle Libre 14
blood glucose monitoring
diabetes
FDA
Flag link:
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Repurposing a GLP-1 diabetes drug to slow Parkinson’s disease
Fierce Biotech
diabetes
Parkinson's Disease
GLP-1 agonist
AstraZeneca
Byetta
Bydureon
Novo Nordisk
Victoza
Ozempic
Eli Lilly
Trulicity
Peptron
Flag link:
Abbott CEO aims for more than one million Libre users by 2019
Abbott CEO aims for more than one million Libre users by 2019
Drug Delivery Business News
Abbott Labs
devices
FreeStyle Libre
diabetes
blood glucose monitoring
Miles White
Flag link:
Medtronic touts one-year data from insulin pump study
Medtronic touts one-year data from insulin pump study
Drug Delivery Business News
Medtronic
Unitedhealthcare Group
diabetes
insulin pumps
devices
Flag link:
3 Best Diabetes Stocks of 2018 So Far
3 Best Diabetes Stocks of 2018 So Far
Motley Fool
diabetes
Tandem Diabetes
DexCom
Senseonics
Flag link:
CHMP Issues Positive Opinion to Expand Labeling of Jardiance, Synjardy and Glyxambi to Include Positive Effects on Cardiovascular and Renal Outcomes
CHMP Issues Positive Opinion to Expand Labeling of Jardiance, Synjardy and Glyxambi to Include Positive Effects on Cardiovascular and Renal Outcomes
CP Wire
CHMP
Boehringer Ingelheim
Eli Lilly
EMA
Jardiance
Synjardy
Glyxambi
diabetes
Flag link:

Pages